中國靜脈血栓栓塞癥研究現(xiàn)狀(參考版)
2024-10-07 01:02本頁面
【正文】 謝謝第二十四 頁 ，共二十四 頁 。高同型半胱氨酸血癥定 義為 高于 對 照 組 90* 或 95百分位水平。 (den Heijer, 1996)2。中國香港： / 1000。靜脈血栓栓塞癥的流行病學(venous thromboembolism, VTE)。AcknowledgmentPeking Union Medical College Bai Chunmei, et al. Natl Med J china, 1999, 79: 900 Bai Chunmei, et al. Chin J Intern Med, 2024, 39: 746 Zhang Xiaofei, et al. Chin J Contr Chron Nonmun Dis, 2024, 9: 206 He Jianguo, et al. Natl Med J china, 2024, 81: 1490 He Jianguo, et al. Natl Med J china, 2024, 82: 1730 Qiu Ling, et al. Acta Acad Med Sin, 2024, 25: 706 Gao Ying, et al. J Cardiovasc Pulmon Dis, 22: 222 Pan Jiaqi, et al. Natl Med J china, 1999, 79: 354 Xu Ling, et al. Chin J Intern Med, 2024, 39: 513Beijing Medical University Yang Gang, et al. Chin J Surg, 2024, 38: 25 Guo Danjie, et al. Chin J Cardiol, 2024, 31: 49 Shanghai Second Medical University Chu Haiyan, et al. Chin J Hematol, 1996, 17: 462 Yang Jingwen, et al. Shanghai Med J, 19: 90Second Military Medical University Wang Meitang, et al. Acad J Sec Mil Med Univ, 2024, 24: 740Chinese Medical University Ao Ran, et al. J Chin Med Univ, 2024, 32: 562Capital Medical University Wang Chen, et al. Chin J Tuberc Respir Dis, 2024, 24: 259第二十三 頁 ，共二十四 頁 。因尚難解釋。即使確如此，原發(fā)病年齡較輕，需進一步證實。的遺傳性缺陷。流行病學研究的證實。Confirmation of PTE HCTPA or Contrast PA if necessaryAnticoagulant therapyFibrinolytic therapy if indicated(+) ()Exclusion of PTEFellowup if necessary()(+)Risk factor screenHCTPA: helical CT pulmonary angiography第二十一 頁 ，共二十四 頁 。2024 Guideline on diagnosis and treatment of PTE The Society of Respiratory diseasesChinese Medical AssociationClinical suspicion of PTEVentilation and perfusion scanCompression ultrasound venography
范文總結相關推薦
鄂ICP備17016276號-1